Fehmi Tabak M.D., Prof. /

Limited Liability Declaration

The content of our website has been created in order to inform the guests. The information provided within the website, can not replace any doctors treatment and consultation. Based on these resources, starting the medication treatment or change of the current treatment are abolutely not recommended. The content of our website, should never be considered for personal diagnosis or any treatment methods. There is no intention regarding the advertisements that are against the law in our website. © 2010 - 2023, All rights are reserved. Privacy Policy. This website is created by CEOTECH . For further information: click.

Ask Question X

“The personal information you provide in the select file section may be of special quality personal data enumerated within the scope of Article 6 of the Personal Data Protection Law (KVKK). These data will be processed, stored and transferred in order to provide online consultancy services in accordance with the decision of "Adequate Measures to be Taken by Data Controllers in the Processing of Special Qualified Personal Data" published by the Personal Data Protection Board.”

I have read the law on protection of personal data, I understood (KVKK)

“With this form, if you contact us via e-mail or telephone, your personal information will be processed by us in order to contact you during the requests, suggestions, complaints and communication processes and to reply to the messages you send, and will be kept by taking the necessary security measures. available here.”

Fehmi Tabak M.D., Prof.

HIV/AIDS

Expert: New HIV/AIDS cases increased 70 percent in 2014

IDWeek 2014: Hepatitis B Relapse Is Common After Stopping Antiviral Therapy

Entecavir and tenofovir both work well against hepatitis B in clinical practice

Entecavir, Tenofovir Comparable in Patients with Treatment-Naïve Chronic Hepatitis B

Ask Question X

Google TranslateX